hotspot -WSS

hotspot

author：explore 2025-09-27 09:46:22 - browse：367

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

Fresh off of the news that its drug Wegovy may not just help people lose weight, but could also lower cardiac risks, Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a small Canadian biotech with a new approach to weight loss.

Novo will spend up to $1 billion to buy Inversago Pharma, which is developing an oral obesity drug that targets the cannabinoid receptor CB1. It’s the second big obesity acquisition this year, following Eli Lilly’s move to purchase startup Versanis Bio.

Drugs like Wegovy are in a class called GLP-1 drugs, which mimic the effects of the glucagon-like peptide 1 hormone that help people feel full by targeting the hormone’s receptors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： FDA needs staff influx to meet gene therapy needs, Marks says

focus

WSS

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Childbirth

FDA approves world's first CRISPR

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Antibiotic resistance nearly killed me, so I'm raising awareness of it

CMS should re

hotspot

hotspot

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Startling documents reveal new facets of Sacklers' opioid empire

At least 13 dead in Texas as scorching temps continue

AI used to predict Covid

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Report: NIH

Hollywood unions extend contract negotiations for actors

Report: NIH

Sports medicine is finally prioritizing gender equality

Childbirth

leisure time

After sickle

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Startling documents reveal new facets of Sacklers' opioid empire

What will save rural psychiatry services? Higher Medicaid payments

Dark money group runs ads on China biotech bill

Chemotherapy shortages won’t get better under Biden’s latest plan

leisure time

Wikipedia

focus

hotspot